2-(8-fluoro-2-methylimidazo[1,2-a]pyridin-6-yl)-6-(2,2,6,6-tetramethylpiperidin-4-yl)-3H-quinazolin-4-one
C25H28FN5O — CID 156888875
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(8-fluoro-2-methylimidazo[1,2-a]pyridin-6-yl)-6-(2,2,6,6-tetramethylpiperidin-4-yl)-3H-quinazolin-4-one
2-(8-fluoro-2-methylimidazo[1,2-a]pyridin-6-yl)-6-(2,2,6,6-tetramethylpiperidin-4-yl)-3H-quinazolin-4-one (PubChem CID 156888875) has the molecular formula C25H28FN5O and a molecular weight of 433.53 g/mol. Its IUPAC name is 2-(8-fluoro-2-methylimidazo[1,2-a]pyridin-6-yl)-6-(2,2,6,6-tetramethylpiperidin-4-yl)-3H-quinazolin-4-one.
Molecular Properties
| Compound Name | 2-(8-fluoro-2-methylimidazo[1,2-a]pyridin-6-yl)-6-(2,2,6,6-tetramethylpiperidin-4-yl)-3H-quinazolin-4-one |
|---|---|
| PubChem CID | 156888875 |
| Molecular Formula | C25H28FN5O |
| Molecular Weight | 433.53 g/mol |
| Exact Mass | 433.23 |
| IUPAC Name | 2-(8-fluoro-2-methylimidazo[1,2-a]pyridin-6-yl)-6-(2,2,6,6-tetramethylpiperidin-4-yl)-3H-quinazolin-4-one |
| SMILES | Cc1cn2cc(-c3nc4ccc(C5CC(C)(C)NC(C)(C)C5)cc4c(=O)[nH]3)cc(F)c2n1 |
| InChI | InChI=1S/C25H28FN5O/c1-14-12-31-13-16(9-19(26)22(31)27-14)21-28-20-7-6-15(8-18(20)23(32)29-21)17-10-24(2,3)30-25(4,5)11-17/h6-9,12-13,17,30H,10-11H2,1-5H3,(H,28,29,32) |
| InChIKey | QGXJSEBPHQXPOS-UHFFFAOYSA-N |
| XLogP | 4.71 |
| TPSA | 75.08 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 433.53 |
| LogP ≤ 5 | 4.71 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156888875 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.